Advanced Search
LI Yanchen, HUA Zongrong, LIU Yao, HUANG Caibin. Advances of CXCL12-CXCR4/CXCR7 Biological Axis in Hepatocellular Carcinoma[J]. Cancer Research on Prevention and Treatment, 2017, 44(9): 636-640. DOI: 10.3971/j.issn.1000-8578.2017.17.0291
Citation: LI Yanchen, HUA Zongrong, LIU Yao, HUANG Caibin. Advances of CXCL12-CXCR4/CXCR7 Biological Axis in Hepatocellular Carcinoma[J]. Cancer Research on Prevention and Treatment, 2017, 44(9): 636-640. DOI: 10.3971/j.issn.1000-8578.2017.17.0291

Advances of CXCL12-CXCR4/CXCR7 Biological Axis in Hepatocellular Carcinoma

  • Hepatocellular carcinoma(HCC) is one of the malignant tumors with the highest morbidity and mortality rates in the world. Studies have shown that CXCL12-CXCR4/CXCR7 biological axis can modulate the growth of HCC cells, angiogenesis, immune escape, invasion and metastasis via autocrine and/or paracrine mechanisms, and may become a new therapeutic target and valuable prognostic marker for HCC. This review aims to summarize the multiple functions of CXCL12-CXCR4/CXCR7 axis in HCC development and progression, as well as the signal transductions that are essential to this process.
  • loading

Catalog

    Turn off MathJax
    Article Contents

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return